Laparoscopic treatment of endometrial cancer: Five-year recurrence and survival rates

J. F. Magrina, A. L. Weaver

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Purpose: To evaluate the 5-year recurrence and survival of patients with clinical Stage I endometrial cancer treated by the laparoscopic approach. Methods: Retrospective review of 56 patients with clinical Stage I endometrial cancer treated laparoscopically. The mean follow-up was 6.4 (4.8-9.6) years. The International Federation of Obstetricians and Gynecologists (FIGO) surgical staging was: I, 45 (80.4%); II, three (5.4%); III, six (10.7%); and IV, two (3.6%). Results: For patients with surgical Stage I (n = 45), the 5-year recurrence rate was 4.9% and the 5-year cause-specific survival was 94.7%. Factors univariately associated with survival were grade (p = .017), depth of myometrial invasion (p = .018), node metastasis (p = .013), and surgical stage according to FIGO (p = .097). Conclusion: The laparoscopic approach provided 5-year survival and recurrence rates similar to those previously attained by laparotomy in our institution.

Original languageEnglish (US)
Pages (from-to)439-441
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Volume25
Issue number4
StatePublished - 2004

Fingerprint

Endometrial Neoplasms
Survival Rate
Recurrence
Survival
Laparotomy
Therapeutics
Neoplasm Metastasis

Keywords

  • Endometrial cancer
  • Hysterectomy
  • Laparoscopic lymphadenectomy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Laparoscopic treatment of endometrial cancer : Five-year recurrence and survival rates. / Magrina, J. F.; Weaver, A. L.

In: European Journal of Gynaecological Oncology, Vol. 25, No. 4, 2004, p. 439-441.

Research output: Contribution to journalArticle

@article{27e7f52a5e784cf6bcf765a604edd19c,
title = "Laparoscopic treatment of endometrial cancer: Five-year recurrence and survival rates",
abstract = "Purpose: To evaluate the 5-year recurrence and survival of patients with clinical Stage I endometrial cancer treated by the laparoscopic approach. Methods: Retrospective review of 56 patients with clinical Stage I endometrial cancer treated laparoscopically. The mean follow-up was 6.4 (4.8-9.6) years. The International Federation of Obstetricians and Gynecologists (FIGO) surgical staging was: I, 45 (80.4{\%}); II, three (5.4{\%}); III, six (10.7{\%}); and IV, two (3.6{\%}). Results: For patients with surgical Stage I (n = 45), the 5-year recurrence rate was 4.9{\%} and the 5-year cause-specific survival was 94.7{\%}. Factors univariately associated with survival were grade (p = .017), depth of myometrial invasion (p = .018), node metastasis (p = .013), and surgical stage according to FIGO (p = .097). Conclusion: The laparoscopic approach provided 5-year survival and recurrence rates similar to those previously attained by laparotomy in our institution.",
keywords = "Endometrial cancer, Hysterectomy, Laparoscopic lymphadenectomy",
author = "Magrina, {J. F.} and Weaver, {A. L.}",
year = "2004",
language = "English (US)",
volume = "25",
pages = "439--441",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "4",

}

TY - JOUR

T1 - Laparoscopic treatment of endometrial cancer

T2 - Five-year recurrence and survival rates

AU - Magrina, J. F.

AU - Weaver, A. L.

PY - 2004

Y1 - 2004

N2 - Purpose: To evaluate the 5-year recurrence and survival of patients with clinical Stage I endometrial cancer treated by the laparoscopic approach. Methods: Retrospective review of 56 patients with clinical Stage I endometrial cancer treated laparoscopically. The mean follow-up was 6.4 (4.8-9.6) years. The International Federation of Obstetricians and Gynecologists (FIGO) surgical staging was: I, 45 (80.4%); II, three (5.4%); III, six (10.7%); and IV, two (3.6%). Results: For patients with surgical Stage I (n = 45), the 5-year recurrence rate was 4.9% and the 5-year cause-specific survival was 94.7%. Factors univariately associated with survival were grade (p = .017), depth of myometrial invasion (p = .018), node metastasis (p = .013), and surgical stage according to FIGO (p = .097). Conclusion: The laparoscopic approach provided 5-year survival and recurrence rates similar to those previously attained by laparotomy in our institution.

AB - Purpose: To evaluate the 5-year recurrence and survival of patients with clinical Stage I endometrial cancer treated by the laparoscopic approach. Methods: Retrospective review of 56 patients with clinical Stage I endometrial cancer treated laparoscopically. The mean follow-up was 6.4 (4.8-9.6) years. The International Federation of Obstetricians and Gynecologists (FIGO) surgical staging was: I, 45 (80.4%); II, three (5.4%); III, six (10.7%); and IV, two (3.6%). Results: For patients with surgical Stage I (n = 45), the 5-year recurrence rate was 4.9% and the 5-year cause-specific survival was 94.7%. Factors univariately associated with survival were grade (p = .017), depth of myometrial invasion (p = .018), node metastasis (p = .013), and surgical stage according to FIGO (p = .097). Conclusion: The laparoscopic approach provided 5-year survival and recurrence rates similar to those previously attained by laparotomy in our institution.

KW - Endometrial cancer

KW - Hysterectomy

KW - Laparoscopic lymphadenectomy

UR - http://www.scopus.com/inward/record.url?scp=3242664564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242664564&partnerID=8YFLogxK

M3 - Article

C2 - 15285298

AN - SCOPUS:3242664564

VL - 25

SP - 439

EP - 441

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 4

ER -